Direct to consumer advertising versus disease awareness advertising: consumer perspectives from down under

At present, only the United States and New Zealand allow direct‐to‐consumer advertising (DTCA) of prescription medicine. In other countries where DTCA is not allowed, including Australia and the United Kingdom, pharmaceutical companies undertake disease awareness advertising (DAA). In DAA, advertise...

Full description

Saved in:
Bibliographic Details
Published in:Journal of public affairs 2011-02, Vol.11 (1), p.60-69
Main Authors: Hall, Danika Valerie, Jones, Sandra Carol, Hoek, Janet
Format: Article
Language:English
Subjects:
Advertising
Attitudes
Australia
Comparative analysis
Consumer advertising
Consumer behavior
Consumers
Diseases
Ethics
Health education
Medical treatment
New Zealand
Perceptions
Pharmaceutical industry
Prescriptions
Studies
United Kingdom
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At present, only the United States and New Zealand allow direct‐to‐consumer advertising (DTCA) of prescription medicine. In other countries where DTCA is not allowed, including Australia and the United Kingdom, pharmaceutical companies undertake disease awareness advertising (DAA). In DAA, advertisements do not name a drug directly, but provide general information about diseases and treatments, and encourage consumers to talk to their doctor. Similar debate surrounds these two forms of advertising, yet while past research has explored consumers' attitudes and behaviour in response to DTCA, little consideration has been given to DAA. This paper compares Australian consumers' perceptions of DAA with New Zealand consumers' perceptions of DTCA. Despite differences in the type and extent of advertising, respondents perceived similar benefits including heightened awareness of treatment options and improved discussions with doctors. New Zealand respondents associated many negative outcomes with DTCA including unbalanced information, inappropriate requests to doctors and consumer confusion. Copyright © 2010 John Wiley & Sons, Ltd.
ISSN:1472-3891
1479-1854
DOI:10.1002/pa.379